You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2426 to 2450 of about 5897
Next 25
10/10/2012
Impact of extent of resection for recurrent glioblastoma on overall survival.
The addition of temozolomide does not change the pattern of progression of glioblastoma multiforme post-radiotherapy.
10/07/2012
Life`s Mountains: What a Brain Tumor Survivor Learned Climbing a Mountain and Battling "Terminal" Cancer
10/03/2012
ImmunoCellular Therapeutics to Present at 3 rd Annual Cancer Immunotherapy Conference and 2012 BIO Investor Forum
Cell Therapeutics` brain cancer drug gets orphan status
09/29/2012
Model T muscle CARs can treat brain tumors.
09/22/2012
The impact of enrollment in clinical trials on survival of patients with glioblastoma.
Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
09/19/2012
Moving Medicine Forward: Breakthroughs in Research
Marijuana And Cancer: Scientists Find Cannabis Compound Stops Metastasis In Aggressive Cancers
IBTA Newsletter
Coated nanoparticles move easily into brain tissue
09/16/2012
Gross Total Resection Rates in Contemporary Glioblastoma Surgery: Results of an Institutional Protocol Combining 5-ALA Intraoperative Fluorescence Imaging and Brain Mapping.
The American Brain Foundation is now accepting video entries to its 2013 Neuro Film Festival.
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Ra2 tumor-restricted biomarker.
The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
09/10/2012
Plym’s journey with brain tumors
09/05/2012
The BrainPower 5K in Austin, TX, is this Sunday, Sept. 9
09/04/2012
Bevacizumab (Avastin) as first-line therapy for glioblastoma.
A*STAR Scientists Discover Potential Drug for Deadly Brain Cance
The Musella Foundation for Brain Tumor Research & Information Inc, announces the awarding of a $40,000 grant to the University Of Pittsburgh Cancer Center - Dr Okada - for the project: Low Grade Glioma Vaccine Trial.
09/03/2012
IBTA E News August 2012
08/30/2012
FDA Approves Novartis Tumor Drug for Children